GLP1R and type 2 diabetes mellitus: Possible candidates for once-weekly insulins are, in our opinion, individuals with type 2 diabetes followed at the outpatient clinic who do not achieve good glycaemic control with metformin, SGLT2i and/or GLP1-RAs or in whom there are contraindications or intolerance to these agents.